| Leanore Miriam Simon, MBBS | |
|
7450 Kessler St Ste 205, Merriam, KS 66204-2553 | |
| (913) 632-9810 | |
| (913) 632-9828 |
| Full Name | Leanore Miriam Simon |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 42 Years |
| Location | 7450 Kessler St Ste 205, Merriam, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528157500 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shawnee Mission Medical Center Inc | 9537119037 | 177 |
News Archive
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
A special spectrometry method that is normally used in analyses of computer chips, lacquers and metals has been further developed at the University of Gothenburg so that it can help researchers better detect harmful cells in the body.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
› Verified 5 days ago
| Entity Name | Shawnee Mission Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992735690 PECOS PAC ID: 9537119037 Enrollment ID: O20050701000310 |
News Archive
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
A special spectrometry method that is normally used in analyses of computer chips, lacquers and metals has been further developed at the University of Gothenburg so that it can help researchers better detect harmful cells in the body.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leanore Miriam Simon, MBBS 7450 Kessler St Ste 205, Merriam, KS 66204-2553 Ph: (913) 632-9810 | Leanore Miriam Simon, MBBS 7450 Kessler St Ste 205, Merriam, KS 66204-2553 Ph: (913) 632-9810 |
News Archive
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ.
Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).
A special spectrometry method that is normally used in analyses of computer chips, lacquers and metals has been further developed at the University of Gothenburg so that it can help researchers better detect harmful cells in the body.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
› Verified 5 days ago
Sherif Aly Ragab, MBBCH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7301 E Frontage Rd Ste 100, Merriam, KS 66204 Phone: 913-789-1900 Fax: 913-789-1901 | |
Dr. Piyushkumar Jani, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: 913-632-2642 Fax: 913-632-2695 | |
Dr. Mariana N Mack, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: -- | |
Sabeen Khaliq, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Merriam, KS 66204 Phone: 913-632-2642 Fax: 913-632-2695 | |
Umang Harshadkumar Shah, M.D., M.P.H. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7301 E Frontage Rd Ste 100, Merriam, KS 66204 Phone: 913-789-1900 Fax: 913-789-1901 |